首页> 美国卫生研究院文献>Health and Quality of Life Outcomes >Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trials

【2h】

Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trials

机译：用于晚期卵巢癌临床试验的18项NCCN / FACT卵巢症状指数及其与疾病相关的症状-物理（DRS-P）分量表的进一步内容验证

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Cognitive interview questions targeted to the four study questions

机译：针对四个学习问题的认知面试问题

著录项

期刊名称 Health and Quality of Life Outcomes
作者
Sara Shaunfield; Sally Jensen; Allison P. Fisher; Kimberly Webster; Shohreh Shahabi; Arijit Ganguli; David Cella;
展开▼
作者单位

展开▼
年(卷),期 2019(17),-1
年度 2019
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类医院、综合医院;中医院;
关键词
Advanced ovarian cancer; Patient reported outcomes; Symptom index; Clinical trials; Content validation; Qualitative methods;

机译：晚期卵巢癌;患者报告的结果;症状指数;临床试验;含量验证;定性方法;

相似文献

外文文献
中文文献
专利

1. Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trials [J] . Sara Shaunfield, Sally Jensen, Allison P. Fisher, Health and Quality of Life Outcomes . 2019,第1期

机译：进一步的内容验证18项NCCN / FACT卵巢症状指数及其疾病相关症状物理（DRS-P）用于晚期卵巢癌临床试验的疾病
2. Re: "cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase II trial." - Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer, the CHORINE study. [J] . AnsaloniL., DeIacoP., FrigerioL. Gynecologic Oncology: An International Journal . 2012,第1期

机译：回复：“细胞减灭术和腹膜内高温化疗作为晚期上皮性卵巢癌的前期治疗：多机构II期临床试验。” -有关CHORINE研究的一项针对晚期卵巢癌的细胞减灭术和腹膜高温化疗的临床试验的建议。
3. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: The National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI) [J] . ButtZ., ParikhN.D., BeaumontJ.L., Cancer: A Journal of the American Cancer Society . 2012,第23期

机译：晚期肝胆和胰腺癌症状指数的开发和验证：癌症治疗的国家综合癌症网络功能评估（NCCN-FACT）肝胆胰腺症状指数（NFHSI）
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Alpha-methylacyl-CoA racemase: A candidate gene for prostate cancer and advanced distal colorectal adenomas in the prostate, lung, colorectal, and ovarian cancer screening trial. [D] . Daugherty, Sarah. 2007

机译：α-甲基酰基辅酶A消旋酶：在前列腺癌，肺癌，结肠直肠癌和卵巢癌筛查试验中，前列腺癌和晚期远端结肠直肠腺瘤的候选基因。
6. Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer [O] . Xingang Peng, Peige Wang, Shikuan Li, 2015

机译：比较奥曲肽和东pol碱丁基溴化物在晚期卵巢癌导致无法手术肠梗阻患者的症状控制中的随机临床试验
7. Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer [O] . 2015

机译：比较奥曲肽和东pol碱丁基溴化物在晚期卵巢癌导致无法手术肠梗阻患者的症状控制中的随机临床试验

Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trials

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅